Aaron Wealth Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Aaron Wealth Advisors’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$508K	Buy	1,388 +121	+10%	+$41.4K	0.02%	438
2026 Q2	$361K	Buy	1,267 +153	+14%	+$45.1K	0.02%	524
2026 Q1	$331K	Buy	1,114 +185	+20%	+$59.9K	0.02%	522
2025 Q4	$282K	Buy	929 +86	+10%	+$28.1K	0.02%	585
2025 Q3	$287K	Buy	843 +15	+2%	+$4.55K	0.02%	534
2025 Q2	$200K	Buy	828 +92	+13%	+$22.6K	0.02%	480
2025 Q1	$200K	Buy	+736	New	+$172K	0.02%	438
2022 Q2	–	Sell	-257	Closed	-$48.5K	–	873
2022 Q1	$48.5K	Buy	+257	New	+$54.6K	0.01%	434

Other funds holding ONC

WAS

WESPAC Advisors SoCal Pasadena, California $553M AUM 26.96% 1-Year Est. Return

HIA

Harbor Investment Advisory Lutherville, Maryland $1.47B AUM 24.2% 1-Year Est. Return

SEIA

Signature Estate & Investment Advisors Los Angeles, California $5.67B AUM 20.02% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

CIA

Cape Investment Advisory Mcdonough, Georgia $388M AUM 17.15% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Aaron Wealth Advisors's ONC Position: Q3 2026 in Review

Aaron Wealth Advisors increased its BeOne Medicines Ltd (ONC) stake by 9.6% in Q3 2026, buying an estimated $41.4K and bringing the position to 1,388 shares worth $508K. The position accounts for 0.02% of the portfolio, ranked #438.

Aaron Wealth Advisors first reported a position in ONC in Q1 2022 and has held it in 8 quarters since. 10 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

Aaron Wealth Advisors held 1,388 shares of BeOne Medicines Ltd worth $508K as of Q3 2026.
Aaron Wealth Advisors bought 121 BeOne Medicines Ltd shares in Q3 2026, an estimated $41.4K.
BeOne Medicines Ltd made up 0.02% of Aaron Wealth Advisors's portfolio in Q3 2026, its #438 holding.
Aaron Wealth Advisors first reported a position in BeOne Medicines Ltd in Q1 2022 and has held it in 8 quarters since.
10 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2026.

Based on Aaron Wealth Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.